William E. Berger

4.5k total citations
115 papers, 3.3k citations indexed

About

William E. Berger is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William E. Berger has authored 115 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Physiology, 77 papers in Immunology and Allergy and 69 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William E. Berger's work include Asthma and respiratory diseases (95 papers), Allergic Rhinitis and Sensitization (77 papers) and Respiratory and Cough-Related Research (49 papers). William E. Berger is often cited by papers focused on Asthma and respiratory diseases (95 papers), Allergic Rhinitis and Sensitization (77 papers) and Respiratory and Cough-Related Research (49 papers). William E. Berger collaborates with scholars based in United States, United Kingdom and Bulgaria. William E. Berger's co-authors include Charles B. Cairns, Eli O. Meltzer, Jonathan A. Bernstein, Anjuli Nayak, Stanley M. Fìneman, Jean Bousquet, Craig LaForce, Niroo Gupta, Angel FowlerTaylor and Richard A. Nicklas and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and CHEST Journal.

In The Last Decade

William E. Berger

110 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Berger United States 33 2.5k 2.0k 1.3k 434 386 115 3.3k
Sharon Sullivan-Rubin France 1 2.0k 0.8× 443 0.2× 1.4k 1.1× 51 0.1× 114 0.3× 2 2.4k
Min‐Hye Kim South Korea 26 1.0k 0.4× 325 0.2× 972 0.7× 82 0.2× 190 0.5× 94 2.2k
Pedro Giavina‐Bianchi Brazil 22 936 0.4× 603 0.3× 608 0.5× 34 0.1× 254 0.7× 136 2.0k
Barbara Knorr United States 27 1.9k 0.8× 518 0.3× 1.6k 1.2× 28 0.1× 74 0.2× 64 2.5k
Kazuto Matsunaga Japan 31 1.4k 0.6× 270 0.1× 1.5k 1.1× 39 0.1× 45 0.1× 149 2.7k
Kyung-Up Min South Korea 24 766 0.3× 387 0.2× 403 0.3× 26 0.1× 234 0.6× 63 2.0k
Christopher H. Fanta United States 24 1.6k 0.7× 248 0.1× 1.5k 1.1× 30 0.1× 88 0.2× 56 2.4k
Sang‐Heon Cho South Korea 20 369 0.2× 417 0.2× 175 0.1× 34 0.1× 187 0.5× 65 1.1k
Graeme P. Currie United Kingdom 25 990 0.4× 255 0.1× 1.0k 0.8× 31 0.1× 47 0.1× 109 1.7k
Ahmad Kantar Italy 22 1.0k 0.4× 89 0.0× 1.3k 1.0× 112 0.3× 41 0.1× 90 2.0k

Countries citing papers authored by William E. Berger

Since Specialization
Citations

This map shows the geographic impact of William E. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Berger more than expected).

Fields of papers citing papers by William E. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Berger. The network helps show where William E. Berger may publish in the future.

Co-authorship network of co-authors of William E. Berger

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Berger. A scholar is included among the top collaborators of William E. Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Berger. William E. Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sher, Ellen & William E. Berger. (2017). Efficacy Analysis of MP-AzeFlu Compared with Fluticasone Propionate Nasal Spray in Children 6 through 11 Years of Age with Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 139(2). AB252–AB252.
3.
Berger, William E., et al.. (2015). Efficacy and safety of beclomethasone dipropionate nasal aerosol in children with perennial allergic rhinitis. Annals of Allergy Asthma & Immunology. 115(2). 130–136. 13 indexed citations
4.
5.
Berger, William E., Shailen Shah, Phil Lieberman, et al.. (2014). Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis. The Journal of Allergy and Clinical Immunology In Practice. 2(2). 179–185. 47 indexed citations
6.
Berger, William E., et al.. (2012). A 26-week Tolerability Study of Ciclesonide Nasal Aerosol in Patients with Perennial Allergic Rhinitis. American Journal of Rhinology and Allergy. 26(4). 302–307. 11 indexed citations
7.
Berger, William E., et al.. (2012). Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis. Allergy and Asthma Proceedings. 33(1). 19–26. 14 indexed citations
8.
Berger, William E., Anjuli Nayak, Bobby Q. Lanier, et al.. (2008). Efficacy and Safety of Once-Daily Ciclesonide Nasal Spray in Children With Allergic Rhinitis. Pediatric Asthma Allergy & Immunology. 21(2). 73–82. 9 indexed citations
9.
Berger, William E.. (2006). What is new in antiimmunoglobulin E asthma therapy.. PubMed. 26(6). 428–34. 4 indexed citations
10.
Corren, Jonathan, William W. Storms, Jonathan A. Bernstein, et al.. (2005). Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clinical Therapeutics. 27(5). 543–553. 56 indexed citations
11.
Berger, William E., Anjuli Nayak, & Heribert Staudinger. (2005). Mometasone Furoate Improves Congestion in Patients with Moderate-to-Severe Seasonal Allergic Rhinitis. Annals of Pharmacotherapy. 39(12). 1984–1989. 25 indexed citations
12.
Berger, William E.. (2005). Paediatric pulmonary drug delivery: considerations in asthma treatment. Expert Opinion on Drug Delivery. 2(6). 965–980. 14 indexed citations
13.
Berger, William E., Paul Y. Qaqundah, Kathryn Blake, et al.. (2005). Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze. The Journal of Pediatrics. 146(1). 91–95. 23 indexed citations
14.
Berger, William E.. (2005). The Safety and Efficacy of Desloratadine for the Management of Allergic Disease. Drug Safety. 28(12). 1101–1118. 26 indexed citations
15.
Murphy, Kevin R. & William E. Berger. (2005). The variability of asthma. Current Medical Research and Opinion. 21(10). 1519–1526. 3 indexed citations
16.
Meltzer, Eli O., Frank C. Hampel, Paul H. Ratner, et al.. (2005). Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Annals of Allergy Asthma & Immunology. 95(6). 600–606. 37 indexed citations
17.
Berger, William E.. (2003). Overview of allergic rhinitis. Annals of Allergy Asthma & Immunology. 90(6). 7–12. 61 indexed citations
18.
Berger, William E.. (2000). Allergies And Asthma for Dummies. 3 indexed citations
19.
Condemi, John J., Paul Chervinsky, Marc F. Goldstein, et al.. (1997). Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. Journal of Allergy and Clinical Immunology. 100(4). 467–474. 44 indexed citations
20.
Leung, Donald Y.M., Jon M. Hanifin, Ernest N. Charlesworth, et al.. (1997). Disease Management of Atopic Dermatitis: a Practice Parameter. Annals of Allergy Asthma & Immunology. 79(3). 197–211. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon Sullivan-Rubin Breakdown of academic impact, for papers by Min‐Hye Kim Breakdown of academic impact, for papers by Pedro Giavina‐Bianchi Breakdown of academic impact, for papers by Barbara Knorr Breakdown of academic impact, for papers by Kazuto Matsunaga Breakdown of academic impact, for papers by Kyung-Up Min Breakdown of academic impact, for papers by Christopher H. Fanta Breakdown of academic impact, for papers by Sang‐Heon Cho Breakdown of academic impact, for papers by Graeme P. Currie Breakdown of academic impact, for papers by Ahmad Kantar
Rankless by CCL
2026